8VU-46829-34707
2 vaccinations
2 coded responses
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 275 / NC
- Registered
- 2022-10-31
- Relationship
- Child or adolescent in my care
- Guardian
- 7U3-16289-66514
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-27
Dose 1 — Moderna
-
2022-07-26
Dose 2 — Moderna
-
2022-10-31
Registered in v-safe
-
2022-10-31
Survey response — 3 months, dose 2, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Cough (occasionally), runny nose (frequently), fever (one day)MedDRA releases: 2024-11 · check-in free text available
-
2023-01-24
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Moderna | No |
| 2 | 2022-07-26 | Moderna | No |
Free text
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: Cough (occasionally), runny nose (frequently), fever (one day)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release